Open AccessMedicineBiology
F. Bifari, V. Lisi, Elda Mimiola, A. Pasini, M. Krampera
2008.5.16TRANSFUSION MEDICINE AND HEMOTHERAPY
Résumé tlooto
By choosing MSC tissue origin, cell dose, administration route, and treatment schedule, all the potential side effects related to MSC use, including tumor growth enhancement, have to be well considered to maximize the benefits of MSC-dependent immune regulation without significant risks for the patients.
Résumé
Le résumé n’est pas disponible.
Format de citation
BIFARI, F., et al. Immune modulation by mesenchymal stem cells. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2008, 35: 194–204.